Orders from 1390 NOK Free delivery from 2895 NOK Ready for pickup dead drop: collect in 5 min Free parcel delivery from 2895 NOK

Scientific and analytical vocabulary

Laboratory and receptor words, said simply

Cards use short codes from chemistry and toxicology. Each entry says what the code is measuring, in everyday words, and shows how a real card uses it. These are analytical reference materials and are not for human consumption.

Receptors and transporters

DAT

Dopamine transporter

DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.

Dopamine is one of the chemical messengers nerve cells use to signal each other. After it crosses the tiny gap between two cells, a protein called the dopamine transporter, DAT, usually collects it again, like a small vacuum on the cell surface. Laboratory papers watch what a compound does to that vacuum. Some compounds slow it down. Others are carried inside, and the cell then releases more dopamine. When a card prints DAT beside a number, it is pointing at this protein and at a published measurement. A smaller EC50 or Ki at DAT means the halfway point of that experiment showed up at a lower concentration. The number is there so a reader can compare a bottle with a paper. It is not a kitchen measure, and it is not an instruction. The material on the card is analytical reference stock and is not for human consumption.

How a card uses it: On a 3-CMC card, DAT is the dopamine-transporter line. One published rat synaptosome assay lists a DAT EC50 near 26 nM. That figure is a concentration in the assay, in nanomoles per litre.

NET

Norepinephrine transporter

NET is the protein that collects norepinephrine, also called noradrenaline, back into the nerve cell. Cards cite it when a lab report shows activity at that transporter.

Norepinephrine, also called noradrenaline, is the messenger textbooks link with the body's alertness signals, including heart rate and the width of blood vessels. NET is the transporter protein that collects it from the gap between nerve cells and brings it back inside. A card that prints NET next to a concentration is saying the cited experiment watched this transporter. As with DAT, a smaller EC50 means the halfway point of that assay arrived at a lower concentration. This is also why stimulant cards place a fast pulse and tight vessels on the hazard side of the page: those words describe load in the toxicology sources, not a benefit. The badge names the protein. It does not tell anyone what to do with the material. Analytical reference only, and not for human consumption.

How a card uses it: A 3-CMC write-up lists a NET EC50 near 19 nM in the same synaptosome paper as the DAT figure. The assay ranked the norepinephrine transporter as slightly more sensitive than the dopamine transporter for that compound.

SERT

Serotonin transporter

SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.

Serotonin is another messenger. SERT is its vacuum: the transporter that collects serotonin from the gap and returns it to the cell. Read a SERT number the same way as a DAT number. If the SERT EC50 is several times higher than the DAT EC50 in the same paper, the serotonin transporter reached its halfway point only at a higher concentration. Authors then call the serotonin reading moderate next to dopamine and norepinephrine. SERT is also why interaction notes appear on the same card. Medicines and other compounds that block this transporter, or that raise serotonin another way, are listed because the sources discuss what happens when those signals stack. The line is a measurement plus a hazard cross-reference. It is not an instruction. Not for human consumption.

How a card uses it: The same 3-CMC synaptosome paper lists a SERT EC50 near 211 nM, beside about 26 nM at DAT. The card can therefore say the serotonin reading was the milder of the three transporter results.

SNDRA / NDRI

Releaser or reuptake blocker

An SNDRA is carried in and the cell releases serotonin, norepinephrine, and dopamine. An NDRI mainly slows the vacuum at norepinephrine and dopamine. The class line says which one the papers describe.

These initials look like a password. They are two different laboratory stories. A substrate-type releaser is carried in through the transporter, and the cell then lets the messenger out. When that happens at serotonin, norepinephrine, and dopamine together, papers say SNDRA: serotonin-norepinephrine-dopamine releasing agent. A reuptake inhibitor does not ask the cell to spill. It slows the vacuum that collects the messenger. NDRI means that slowing shows up at norepinephrine and dopamine, with little serotonin in the same assays. SNDRI means the block includes serotonin too. NDRA means release at norepinephrine and dopamine, without the serotonin part. 3-CMC is filed as an SNDRA. A pyrovalerone such as alpha-PVP is filed as an NDRI. The class line tells you which experiment is being quoted. It is not a promise about an experience, and the material is not for human consumption.

How a card uses it: The 3-CMC class line says stimulant / entactogen (SNDRA) because the cited synaptosome work measured release. The NEP class line says selective NDRI because the papers describe reuptake block at NET and DAT.

GABAₐ

GABA-A positive modulator

GABA-A is the main inhibitory receptor for the messenger GABA. A positive modulator does not replace GABA. It makes GABA's own signal stronger when GABA is already there.

GABA is the messenger that tells many nerve cells to fire less. Its main receptor is GABA-A, a small channel that lets chloride ions through when GABA sits on it. A positive allosteric modulator, a PAM, binds at a side site on that same receptor. It does not switch the receptor on by itself the way GABA does. It changes the shape so that GABA, when it arrives, opens the channel more readily. Benzodiazepine-type compounds and thienodiazepines such as etizolam are the usual examples on these cards. Papers sometimes add a subunit, such as alpha-1 or alpha-2, because those subunits are linked in the literature to different parts of the signal. The safety note beside this badge is serious. Toxicology sources describe dangerous slowing of breathing when a GABA-A modulator is combined with opioids, alcohol, or similar depressant classes. The badge explains the receptor. It is not a suggestion to use the material. Not for human consumption.

How a card uses it: An etizolam card says GABA-A positive allosteric modulator, thienodiazepine, and shows a tablet marked 1 tablet = 1 mg. The sentence names the receptor family and the labeled content of one unit.

5-HT₂ₐ

Serotonin receptor 5-HT2A

5-HT is the laboratory name for serotonin. 2A is one subtype of its receptor. Lysergamide, tryptamine, and many 2C-family cards cite this receptor.

Serotonin's short laboratory name is 5-HT, from 5-hydroxytryptamine. There is not one serotonin receptor. There is a family, and 2A is the subtype that lysergamide, tryptamine, and many phenethylamine papers keep returning to. A card that prints 5-HT2A is saying this is the receptor the cited experiment measured, often with a Ki or an EC50 in nanomoles. Partial agonist means that, in that test, the climb of the response stopped short of the maximum a reference compound reached. Full agonist means the climb reached that top. The glossary stops at the measurement. It does not describe an experience. Interaction lines on these cards often flag MAOIs, because stacking serotonin signaling is a documented toxicology hazard. Not for human consumption.

How a card uses it: A 1P-LSD class line that says lysergamide prodrug and 5-HT2A partial agonist is two facts: enzymes are described as converting the listed molecule, and the related molecule is discussed at the 5-HT2A receptor.

NMDA

NMDA glutamate channel

NMDA is a glutamate receptor that works like a gated channel. Ketamine-type and PCP-type cards cite it when papers describe that channel as blocked.

Glutamate is the main go-messenger in neuroscience textbooks. NMDA is one of its receptors, and it is also an ion channel: a pore that opens when the right signals arrive. Compounds in the arylcyclohexylamine family, including ketamine and the PCP- and PCE-type reference materials, are described in papers as blockers that sit in that pore rather than simply competing at the glutamate site. A card that prints NMDA is pointing at that mechanism. Some of the same papers also mention a weaker reading at a transporter such as SERT or DAT. Those extra lines are secondary measurements. The NMDA badge is the primary one. This is a description of a published mechanism, not guidance. The material is not for human consumption.

How a card uses it: A ketamine class line that says short-acting NMDA receptor antagonist means the cited work treats block of the NMDA channel as the main laboratory finding.

CB₁ / CB₂

Cannabinoid receptors CB1 and CB2

CB1 and CB2 are the two cannabinoid receptors named on these cards. Papers usually discuss CB1 in the nervous system and CB2 more often in immune tissue. The number beside them is often a Ki in nanomoles.

The body makes its own cannabinoid-like messengers. Plant cannabinoids and synthetic cannabinoid reference compounds are studied at two receptors named CB1 and CB2. In the papers cited on these cards, CB1 is the receptor discussed in the nervous system, and CB2 is discussed more often in immune tissue. A full agonist reaches the top of the measured response in that test. A partial agonist levels off earlier, which is how many papers describe THC at CB1. Synthetic cannabinoid cards often list a Ki below 1 nanomole, which means very tight binding in that binding assay. Tight binding in a dish is a chemistry fact. It is also why the toxicology notes on those cards are stern. The badge explains the two receptors. It is not an invitation. Not for human consumption.

How a card uses it: A class line that says full CB1/CB2 agonist with a sub-nanomolar Ki is saying both receptors were occupied at a very low concentration in the cited binding test.

μ

Mu opioid receptor

Mu, written μ, is the opioid receptor subtype that opioid papers treat as the main one. O-DSMT cards cite it, and the same cards warn about breathing when depressant classes are combined.

Opioid receptors come in several subtypes. Mu, written with the Greek letter μ, is the one analgesic and toxicology papers treat as primary for compounds such as O-DSMT. A card that says mu agonist means the cited experiment saw the compound activate that receptor. Some of these molecules also block the norepinephrine transporter, so a NET line can sit beside the mu line. The hazard that belongs with this badge is respiratory depression: the drive to breathe can become too weak, especially when a mu agonist is combined with a GABA-A modulator, alcohol, or another depressant class. Read the badge as a receptor name plus that warning. The material is analytical reference stock and is not for human consumption.

How a card uses it: The O-DSMT class line says mu-opioid receptor agonist and norepinephrine reuptake inhibitor. The card names two laboratory actions, and the critical-hazard group lists combinations that suppress breathing.

Numbers, curves, and time

EC₅₀ / IC₅₀

Halfway concentration

EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.

These two look like passwords. They are halfway marks on a laboratory graph. The team prepares many concentrations and measures a response: messenger released, transporter blocked, receptor occupied. Put concentration along the bottom and the response up the side, and you usually get an S-shaped curve. EC50, effective concentration 50, is the point where the response is halfway to its maximum. IC50, inhibitory concentration 50, is the same idea when the thing being measured is a block: halfway to the strongest block. The 50 is not a purity grade, and it is not a human amount. On these cards the unit is almost always nanomolar, nM, a count of molecules per litre in the assay. A 19 nM EC50 and a 211 nM EC50 can be compared when they were measured the same way. A smaller number means the halfway point showed up at a lower concentration in that experiment. Different labs will not match to the last digit. The card is quoting a paper, not issuing an instruction. Not for human consumption.

How a card uses it: For 3-CMC, one cited synaptosome paper lists NET EC50 about 19 nM, DAT about 26 nM, and SERT about 211 nM. All three are halfway points on release curves, not amounts printed as a schedule.

Kᵢ

Binding tightness in nanomoles

Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.

Ki comes from a binding experiment. The letter i stands for inhibition. The lab mixes the compound with a receptor and a known labeled marker, then asks how much compound it takes to push the marker off. The answer is a concentration. Nanomolar means nanomoles per litre. One nanomole is a billionth of a mole, so these are tiny concentrations in a dish, not a scoop in a kitchen. A Ki of 0.2 nM is tighter, in that test, than a Ki of 50 nM. Tighter does not automatically mean stronger in every other assay. EC50 and IC50 ask what happens when the receptor signals. Ki asks how willingly the compound sits there. Cannabinoid cards, and some NMDA and 5-HT2A cards, quote Ki because binding data are what those papers published. Compare Ki values that come from similar experiments. Not for human consumption.

How a card uses it: A synthetic cannabinoid card that says sub-nanomolar CB1 Ki is saying the binding halfway point sat below 1 nM in the cited test. That is a tightness figure. It is not the same experiment as an EC50, even though both use the nanomolar unit.

ratio

Selectivity ratio

A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.

One number on its own says halfway at this concentration. A ratio says halfway here compared with halfway there. If the SERT EC50 is 211 nM and the DAT EC50 is 26 nM, then 211 divided by 26 is about 8. Authors call that a SERT/DAT ratio near 8, and they read it as: the dopamine transporter's halfway point arrived at a lower concentration than the serotonin transporter's. Flip the division and the number flips, so the card or the paper has to say which way it was divided. Selective in a class line, such as selective NDRI, is the same idea in words: the cited assays showed a clear preference, not an equal reading at every target. A GABA-A card that says alpha-2 leaning is also a selectivity statement, this time among receptor subunits. Ratios compare papers. They are not a household measure. Not for human consumption.

How a card uses it: The 3-CMC note uses a SERT/DAT EC50 ratio near 8 to say the cited assay was more sensitive at DAT than at SERT. A 2-CMC class line that says selective NDRA is the word form of a similar idea: norepinephrine and dopamine, not a balanced serotonin reading.

curve

Concentration-response curve

The response curve plots concentration along the bottom and the measured laboratory response up the side. It is usually flat, then steep, then flat again near the top. EC50 sits on the steep middle.

Picture a graph. Along the bottom you increase the concentration. Up the side you record whatever the instrument measured: messenger released, channel blocked, receptor occupied. At a very low concentration the line barely moves. Then it climbs. Then it levels off because the system is already at its maximum for that test. That S-shape is the concentration-response curve. The useful part for reading a card is the steep middle. A steep curve means a small step in concentration changed the reading a lot. A shallow curve means the reading changed more gradually. EC50 is the dot halfway up the climb, not the top and not the bottom. Partial agonist means the climb leveled off below the maximum that a reference compound reached in the same setup. None of these shapes is an instruction. They are how the paper drew the result. Not for human consumption.

How a card uses it: A GABA-A card is talking about this curve even when it does not print one. Positive modulator means that, in the published graphs, GABA's own climb got steeper or taller when the compound was also in the dish. The halfway dot on that climb is the EC50.

T½

Half-life

Half-life is the time it takes a measured concentration to fall by half. After one half-life, half remains. After another, a quarter of the original measurement remains.

T½ is a clock for a fading measurement. If a paper says the plasma half-life is 8 hours, then in that pharmacokinetic model the measured amount falls to half in 8 hours, to a quarter in 16 hours, and so on. It is not a promise that every trace is gone, and it is not the same number as the length of an observation window in a paper. A metabolite can have its own half-life, longer or shorter than the parent molecule. Etizolam cards mention an active hydroxylated metabolite with a half-life around 8 hours. That is exactly this kind of table entry. Long-half-life GABA-A compounds are classed that way because the published clock is long, so later measurements are still discussed in those papers. The storage life of a dry powder is a different clock: that one is about the chemical sitting in the jar, not about a blood measurement. When the card says T½, check which clock it means. Not for human consumption.

How a card uses it: The etizolam metabolite note says alpha-hydroxyetizolam has a half-life around 8 hours. Read that as: in the cited pharmacokinetic description, the measured concentration of that metabolite fell by half in about 8 hours.

prodrug

Prodrug

A prodrug is a molecule that stays chemically quiet until enzymes convert it into a related molecule. The card names that relationship when the class line says prodrug.

Some catalog entries are not filed as the molecule a paper measures at the receptor. They are filed one step upstream in metabolism. Enzymes clip or reshape the listed molecule into a related one, and that related one is what the binding or signaling papers discuss. 1P-LSD, 1cP-LSD, and 1V-LSD are classed as lysergamide prodrugs. 4-AcO-DMT is classed the same way relative to psilocin. The card is telling you about a chemical conversion described in the literature. It is not a recipe, and it does not say what anyone should do with the vial. The word sits in the numbers section because the relationship is about what the measurement refers to, not about a clock. Analytical reference only. Not for human consumption.

How a card uses it: A class line that reads N1-acylated lysergamide prodrug, 5-HT2A partial agonist, is two facts at once: enzymes are described as converting the listed molecule, and the related molecule is discussed at the 5-HT2A receptor.

Chemistry and physical form

isomer

Isomers

Isomers share the same atoms in the same counts, but the atoms are arranged differently. They can share a molecular formula and still be different chemicals, with different CAS numbers and different lab results.

Same pieces, different shape. Isomers contain the same atoms in the same counts, which is why the molecular formula matches, but the atoms are connected differently or point a different way in space. Positional isomers are the easy picture. 2-CMC, 3-CMC, and 4-CMC all have the formula C10H12ClNO, and the chlorine sits on a different carbon of the ring. That one-carbon move is enough for transporter assays to report different EC50 values, and enough for the registry to assign different CAS numbers. The formula on its own cannot tell the bottles apart. The IUPAC name can, because it states the position. A salt and its free base are not isomers of each other. They are the same parent with or without an acid partner, and they often have two CAS numbers for that reason. When a card says positional isomer, it is warning you that a lookalike formula is not the same identity. Not for human consumption.

How a card uses it: 3-CMC, 4-CMC, and 2-CMC share C10H12ClNO. Published assays still list different DAT EC50 figures for them, and each has its own CAS. The isomer note stops a matching formula from being mistaken for a matching bottle.

CAS

CAS registry number

A CAS number is a passport number for one chemical entry in the CAS registry. The free base and a salt of the same parent usually have different CAS numbers.

CAS stands for Chemical Abstracts Service. The registry gives a hyphenated number to one defined chemical substance. It looks like 40054-69-1 or 1049677-59-9. It is not a purity grade and it is not a safety approval. It is an identity key, the way a library gives one call number to one book. The useful catch is that the free base and a salt, such as a hydrochloride, are different registry entries. A bottle of the salt can carry a different CAS from the parent molecule named in a paper. Hydrates can differ too. When you compare a card with a publication, match the CAS to the exact form named, not only to the short nickname. Two isomers never share a CAS. If a quoted number and the card disagree, the structures disagree. Not for human consumption.

How a card uses it: Etizolam's parent CAS on the card is 40054-69-1. 3-CMC lists freebase CAS 1049677-59-9 and a different hydrochloride CAS, because the salt is a separate registry entry.

IUPAC

IUPAC Name & Molecular Formula

The molecular formula counts how many atoms of each element sit in one molecule, while the IUPAC name is the systematic map showing exactly how those atoms are connected.

Two different substances can share the exact same molecular formula (for example C10H12ClNO for both 3-CMC and 4-CMC). The IUPAC name removes all ambiguity by numbering every ring position and side chain.

How a card uses it: 3-CMC and 4-CMC both have the formula C10H12ClNO, but their IUPAC names place the chlorine atom at position 3 versus position 4.

CID / InChIKey

PubChem CID & Standard InChIKey

PubChem CID is the catalog number in the U.S. National Library of Medicine chemistry database, and InChIKey is a 27-character digital fingerprint of the molecule's exact 3D structure.

Clicking the PubChem CID on any of our cards opens the official government repository record so you can independently verify the molecular weight, structure, and literature links.

How a card uses it: CID 50999285 links directly to the public PubChem record for 3-CMC.

GC-MS / NMR

GC-MS & NMR Analytical Testing

Laboratory analytical methods that separate a sample and read its structural spectrum to verify exact identity and >=98% purity.

Laboratory analytical methods that separate a sample and read its structural spectrum to verify exact identity and >=98% purity.

How a card uses it: Laboratory analytical methods that separate a sample and read its structural spectrum to verify exact identity and >=98% purity.

1 mg / µg

Calibrated Physical Form (1 mg Tablets, µg Liquid, Crystal)

Milligram-scale benzodiazepines are supplied as 1 mg tablets (1 tablet = 1 mg), microgram lysergamides as dissolved liquid (µg), and standard compounds as pure crystal or powder.

Milligram-scale benzodiazepines are supplied as 1 mg tablets (1 tablet = 1 mg), microgram lysergamides as dissolved liquid (µg), and standard compounds as pure crystal or powder.

How a card uses it: Milligram-scale benzodiazepines are supplied as 1 mg tablets (1 tablet = 1 mg), microgram lysergamides as dissolved liquid (µg), and standard compounds as pure crystal or powder.

Prekursor

Chemical Precursor (Non-Neuroactive Intermediate)

A chemical synthesis starting material (such as 2B3C or 2C-H) that has no central nervous system activity of its own and requires standard laboratory handling precautions.

A chemical synthesis starting material (such as 2B3C or 2C-H) that has no central nervous system activity of its own and requires standard laboratory handling precautions.

How a card uses it: A chemical synthesis starting material (such as 2B3C or 2C-H) that has no central nervous system activity of its own and requires standard laboratory handling precautions.

Safety and interactions

MAOI / IMAO

Monoamine Oxidase Inhibitors (MAOIs)

Compounds and medications that block the enzyme responsible for breaking down serotonin, dopamine, and norepinephrine; combining them with monoamine releasers is life-threatening.

Compounds and medications that block the enzyme responsible for breaking down serotonin, dopamine, and norepinephrine; combining them with monoamine releasers is life-threatening.

How a card uses it: Compounds and medications that block the enzyme responsible for breaking down serotonin, dopamine, and norepinephrine; combining them with monoamine releasers is life-threatening.

5-HT ↑↑

Serotonergic Overload (Serotonin Toxicity)

A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.

A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.

How a card uses it: A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.

OUN / Oddech

Synergistic CNS & Respiratory Depression

Combining two central nervous system depressants (such as benzodiazepines, alcohol, GHB, or opioids) multiplies sedation and can suppress brainstem breathing drive.

Combining two central nervous system depressants (such as benzodiazepines, alcohol, GHB, or opioids) multiplies sedation and can suppress brainstem breathing drive.

How a card uses it: Combining two central nervous system depressants (such as benzodiazepines, alcohol, GHB, or opioids) multiplies sedation and can suppress brainstem breathing drive.

HR / Naczynia

Vasoconstriction & Cardiovascular Load

Narrowing of peripheral blood vessels, elevated blood pressure, and rapid heart rate driven by strong noradrenergic and dopaminergic stimulation.

Narrowing of peripheral blood vessels, elevated blood pressure, and rapid heart rate driven by strong noradrenergic and dopaminergic stimulation.

How a card uses it: Narrowing of peripheral blood vessels, elevated blood pressure, and rapid heart rate driven by strong noradrenergic and dopaminergic stimulation.

Tolerancja ×

Cross-Tolerance

When exposure to one compound reduces sensitivity to other compounds that act on the same receptor family (for example across all 5-HT2A lysergamides or all GABA-A modulators).

When exposure to one compound reduces sensitivity to other compounds that act on the same receptor family (for example across all 5-HT2A lysergamides or all GABA-A modulators).

How a card uses it: When exposure to one compound reduces sensitivity to other compounds that act on the same receptor family (for example across all 5-HT2A lysergamides or all GABA-A modulators).

SSRI / SNRI

SSRI & SNRI Medications

Common prescription medications that occupy the serotonin transporter (SERT), blunting certain receptor effects while still carrying interaction risks with strong monoamine releasers.

Common prescription medications that occupy the serotonin transporter (SERT), blunting certain receptor effects while still carrying interaction risks with strong monoamine releasers.

How a card uses it: Common prescription medications that occupy the serotonin transporter (SERT), blunting certain receptor effects while still carrying interaction risks with strong monoamine releasers.